Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.

Giorgio Carmelo Giannitto,Dario Giuffrida,Alessandro Pappalardo,Antonio Russo,Bruno Vincenzi,Salvino Saita,Enrico Potenza,Franco Marletta,Giuseppe La Venia,Sergio Castorina,Roberto Bordonaro

Paclitaxel, carboplatin and gemcitabine combination as induction chemotherapy for stage IIIA N2 bulky non-small cell lung cancer.

2005

Giorgio Carmelo Giannitto
Dario Giuffrida
Alessandro Pappalardo
Antonio Russo
Bruno Vincenzi
Salvino Saita
Enrico Potenza
Franco Marletta
Giuseppe La Venia
Sergio Castorina
Roberto Bordonaro

Background: Induction chemotherapy followed by surgical resection or definitive radiotherapy for patients affected by stage IIIA N2 bulky non-small cell lung cancer (NSCLC) has been

Keywords:

Carboplatin
Immunology
Pathology
Cancer
Gemcitabine
Antimetabolite
Medicine
Radiation therapy
Lung cancer
Induction chemotherapy
Chemotherapy
Paclitaxel

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations